SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Qualcomm Moderated Thread - please read rules before posting -- Ignore unavailable to you. Want to Upgrade?


To: Rich Bloem who wrote (67895)8/18/2007 2:39:27 PM
From: Art Bechhoefer  Read Replies (1) | Respond to of 197271
 
761 is a continuation patent whose parent is U.S. Pat No. 7,031,687

Does anyone suspect (besides me) that this continuation patent may be invalid, in lieu of the Supreme Court decision in the KSR-Teleflex case? Continuation patents as a group may now be deemed obvious. This is the very issue that worries drug firms, who have enthusiastically used minor variations in drugs going off patent protection to prolong their exclusivity.

Art